Trends in Immunology

TRENDS IN IMMUNOLOGY is a leading monthly review journal published by Cell Press, a premier imprint of Elsevier. With an ISSN of 1471-4906 and an impact factor of 13.100 (2026), it is consistently ranked in the top quartile (Q1) of the JCR Immunology category, solidifying its standing as one of the most influential and authoritative voices in the field. The journal’s scope encompasses the full breadth of contemporary immunology, from fundamental molecular and cellular mechanisms to translational advances in immunotherapy, autoimmunity, infectious disease, and vaccine development. It serves as a critical platform for synthesizing rapidly evolving research areas, including immune regulation, innate immunity, tumor immunology, and mucosal immunology. TRENDS IN IMMUNOLOGY exclusively publishes commissioned, high-impact review articles, including Opinions, Reviews, and short “Science & Society” pieces, which are designed to provide expert synthesis and forward-looking perspectives rather than original primary research. The journal also features “Spotlight” and “Forum” articles that offer concise commentary on recent breakthroughs. Its target audience consists of professional immunologists, academic researchers, clinicians with a focus on immunopathology, and advanced graduate students seeking authoritative, accessible overviews of complex topics. A notable feature of the journal is its commitment to clarity and conceptual insight, making it an essential resource for staying current without the granular detail of primary data. While not an open-access journal by default, authors may choose to publish their articles open access under a Creative Commons license. As a cornerstone of the Trends series, this journal is indispensable for anyone seeking a comprehensive, critical, and timely understanding of immunology’s most dynamic frontiers.